Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients

Background. The detection of antiphospholipid antibodies (aPL) is of interest because of their importance in the pathogenesis of arterial or venous thrombosis. They could be a “second hit” of an inflammatory event such as infection. The aim of our study was to assess the performance of antiphospholi...

Full description

Saved in:
Bibliographic Details
Main Authors: Amal Abouda, Z. Hajjej, A. Mansart, W. Kaabechi, D. Elhaj Mahmoud, O. Lamine, E. Ghazouani, M. Ferjani, I. Labbene
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/9775111
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565788653912064
author Amal Abouda
Z. Hajjej
A. Mansart
W. Kaabechi
D. Elhaj Mahmoud
O. Lamine
E. Ghazouani
M. Ferjani
I. Labbene
author_facet Amal Abouda
Z. Hajjej
A. Mansart
W. Kaabechi
D. Elhaj Mahmoud
O. Lamine
E. Ghazouani
M. Ferjani
I. Labbene
author_sort Amal Abouda
collection DOAJ
description Background. The detection of antiphospholipid antibodies (aPL) is of interest because of their importance in the pathogenesis of arterial or venous thrombosis. They could be a “second hit” of an inflammatory event such as infection. The aim of our study was to assess the performance of antiphospholipid antibody biomarker to predict in-hospital mortality in intensive care unit (ICU) septic patients. Methods. We conducted a prospective single-center observational study including consecutive critically ill septic adults admitted to the intensive care unit. Clinical and laboratory data including enzyme-linked immunosorbent assay for antiphospholipid antibodies (anticardiolipin (aCL), antiphosphatidylserine (aPS)) were obtained. Blood samples were collected on days 1, 3, 5, 8, and 10 of hospitalization. The primary study endpoint was ICU mortality defined as death before ICU discharge. Secondary end points included correlation between SOFA score and biological parameters. Results. A total of 53 patients were enrolled. 18.8% of patients were aPL positive. In-hospital mortality rate was 60%. Multivariate analysis showed that age and aCL at days 3 and 5 along with SOFA at day 3 were independent outcome predictors. A significant positive correlation existed between SOFA at days 3, 5, and 8 and antiphospholipid antibody concentrations. Conclusions. Our data showed that antiphospholipid was useful biomarkers for the prediction of mortality in critically ill septic patients. We found a positive correlation between SOFA score and antiphospholipid antibodies.
format Article
id doaj-art-70faa5b3c1a144f19b13ac2a8e8de67d
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-70faa5b3c1a144f19b13ac2a8e8de67d2025-02-03T01:06:38ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/9775111Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic PatientsAmal Abouda0Z. Hajjej1A. Mansart2W. Kaabechi3D. Elhaj Mahmoud4O. Lamine5E. Ghazouani6M. Ferjani7I. Labbene8Intensive Care UnitIntensive Care UnitUniversity of Paris-SaclayMedicine Faculty of TunisImmuno-Rheumatology Research LaboratoryDepartment of BiochemistryLaboratory of ImmunologyIntensive Care UnitIntensive Care UnitBackground. The detection of antiphospholipid antibodies (aPL) is of interest because of their importance in the pathogenesis of arterial or venous thrombosis. They could be a “second hit” of an inflammatory event such as infection. The aim of our study was to assess the performance of antiphospholipid antibody biomarker to predict in-hospital mortality in intensive care unit (ICU) septic patients. Methods. We conducted a prospective single-center observational study including consecutive critically ill septic adults admitted to the intensive care unit. Clinical and laboratory data including enzyme-linked immunosorbent assay for antiphospholipid antibodies (anticardiolipin (aCL), antiphosphatidylserine (aPS)) were obtained. Blood samples were collected on days 1, 3, 5, 8, and 10 of hospitalization. The primary study endpoint was ICU mortality defined as death before ICU discharge. Secondary end points included correlation between SOFA score and biological parameters. Results. A total of 53 patients were enrolled. 18.8% of patients were aPL positive. In-hospital mortality rate was 60%. Multivariate analysis showed that age and aCL at days 3 and 5 along with SOFA at day 3 were independent outcome predictors. A significant positive correlation existed between SOFA at days 3, 5, and 8 and antiphospholipid antibody concentrations. Conclusions. Our data showed that antiphospholipid was useful biomarkers for the prediction of mortality in critically ill septic patients. We found a positive correlation between SOFA score and antiphospholipid antibodies.http://dx.doi.org/10.1155/2022/9775111
spellingShingle Amal Abouda
Z. Hajjej
A. Mansart
W. Kaabechi
D. Elhaj Mahmoud
O. Lamine
E. Ghazouani
M. Ferjani
I. Labbene
Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients
Journal of Immunology Research
title Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients
title_full Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients
title_fullStr Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients
title_full_unstemmed Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients
title_short Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients
title_sort anticardiolipin autoantibodies as useful biomarkers for the prediction of mortality in septic patients
url http://dx.doi.org/10.1155/2022/9775111
work_keys_str_mv AT amalabouda anticardiolipinautoantibodiesasusefulbiomarkersforthepredictionofmortalityinsepticpatients
AT zhajjej anticardiolipinautoantibodiesasusefulbiomarkersforthepredictionofmortalityinsepticpatients
AT amansart anticardiolipinautoantibodiesasusefulbiomarkersforthepredictionofmortalityinsepticpatients
AT wkaabechi anticardiolipinautoantibodiesasusefulbiomarkersforthepredictionofmortalityinsepticpatients
AT delhajmahmoud anticardiolipinautoantibodiesasusefulbiomarkersforthepredictionofmortalityinsepticpatients
AT olamine anticardiolipinautoantibodiesasusefulbiomarkersforthepredictionofmortalityinsepticpatients
AT eghazouani anticardiolipinautoantibodiesasusefulbiomarkersforthepredictionofmortalityinsepticpatients
AT mferjani anticardiolipinautoantibodiesasusefulbiomarkersforthepredictionofmortalityinsepticpatients
AT ilabbene anticardiolipinautoantibodiesasusefulbiomarkersforthepredictionofmortalityinsepticpatients